IL0011407140
IL0011407140
UroGen Pharma Ltd.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 109.788.000 | 90.398.000 | 21.4% |
| Cost of Revenue | 12.447.000 | 8.881.000 | 40.2% |
| Gross Profit | 97.341.000 | 81.517.000 | 19.4% |
| 222.204.000 | 178.299.000 | 24.6% | |
| Operating Income | -124.863.000 | -96.782.000 | 29.0% |
| Pretax Income | -153.416.000 | -124.042.000 | 23.7% |
| Net Income Common Stockholders | -153.494.000 | -126.874.000 | 21.0% |
| -- | -- | -- | |
| -- | -- | -- |